# FDA Inspection 996815 - Hikal Limited - November 18, 2016

Source: https://www.keypedia.com/records/fda_inspections/hikal-limited/71b470bc-cfad-4a11-94c5-01394d20e055
Source feed: FDA_Inspections

> FDA Inspection 996815 for Hikal Limited on November 18, 2016. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 996815
- Company Name: Hikal Limited
- Inspection Date: 2016-11-18
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1260407 - 2025-02-07](https://www.keypedia.com/records/fda_inspections/hikal-limited/296e2d15-1773-4aa0-8658-5b558cd5d278)
- [FDA Inspection 1260407 - 2025-02-07](https://www.keypedia.com/records/fda_inspections/hikal-limited/b52ed376-e8c5-4981-9ff0-1255c352c996)
- [FDA Inspection 1260407 - 2025-02-07](https://www.keypedia.com/records/fda_inspections/hikal-limited/eddabad7-2a62-4c31-a326-86c041951716)
- [FDA Inspection 1260407 - 2025-02-07](https://www.keypedia.com/records/fda_inspections/hikal-limited/f53f4db4-9b1e-4bd4-ae06-e034f73c71fc)
- [FDA Inspection 1105799 - 2019-08-02](https://www.keypedia.com/records/fda_inspections/hikal-limited/38f466d0-7141-40dd-a116-c5bdd5b5cf44)

Company: https://www.keypedia.com/companies/hikal-limited/cb3e9445-04eb-4d52-af78-793b43f9d61f

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c